RxDoctor Payments Data

Patrick Nettles, PA

Physician Assistant · Darlington, SCNPI 1285235457

Payments from drug & device makers

$3,952in general payments, 2019–2025

Across 225 payments — averaging $17.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Axsome Therapeutics, Inc.$547
  • Alkermes, Inc.$163
  • Takeda Pharmaceuticals U.S.A., Inc.$137
  • Otsuka America Pharmaceutical, Inc.$132
  • E.r. Squibb & Sons, L.L.C.$122
  • plus $617 from 17 others

What the payments were for

  • Food & beverage$3,952100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,952 in reported general payments places this provider in the 85th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Medicare billing

Part B allowed, 2024
$985
Medicare patients
22
Services billed
30

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine13$120,692
VraylarCariprazine Hcl64$100,869
Abilify MaintenaAripiprazole20$54,249
OzempicSemaglutide27$27,002
AuvelityDextromethorphan Hbr/Bupropion20$23,849
XanaxAlprazolam34$21,669
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,901
Venlafaxine Hcl ErVenlafaxine Hcl39$2,921
Bupropion XlBupropion Hcl38$1,146
Prazosin Hcl22$1,071
Trazodone Hcl60$968
Albuterol Sulfate HfaAlbuterol Sulfate41$905
Gabapentin59$823
Doxepin Hcl16$730
Quetiapine Fumarate44$722

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr$58$120,69213 claims
AbbVieVraylar$2,234$100,86964 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$132$54,24920 claims
Novo NordiskOzempic$75$27,00227 claims
Axsome Therapeutics, Inc.Auvelity$547$23,84920 claims
AstraZenecaBreztri Aerosphere$16$7,90112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,852 physician assistant providers in South Carolina.

Other physician assistant in Darlington

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →